Carta Acesso aberto Revisado por pares

Cryosurgery for the treatment of cutaneous sporotrichosis: experience with 199 cases

2018; Oxford University Press; Volume: 180; Issue: 6 Linguagem: Inglês

10.1111/bjd.17532

ISSN

1365-2133

Autores

Vivian Fichman, Antônio Carlos Francesconi do Valle, Dayvison Francis Saraiva Freitas, Felipe Maurício Soeiro Sampaio, Marcelo Rosandiski Lyra, Priscila Marques de Macedo, Rodrigo Almeida‐Paes, Raquel de Vasconcellos Carvalhães de Oliveira, Maria Clara Gutierrez‐Galhardo,

Tópico(s)

Cutaneous lymphoproliferative disorders research

Resumo

Sporotrichosis is a worldwide distributed subcutaneous mycosis caused by the dimorphic fungi belonging to the genus Sporothrix.1 Since 1998, Rio de Janeiro (RJ), Brazil, became a hyperendemic region for cat-transmitted zoonotic sporotrichosis associated with the most virulent species, S. brasiliensis.1,2 Itraconazole is the first choice of treatment for cutaneous sporotrichosis, terbinafine and potassium iodide are alternative options. The median time until the cure is around 12 weeks, but it can be longer for some patients and adverse effects may lead to discontinuation of treatment.2-5 Cryosurgery is an effective method largely used in dermatology. This article is protected by copyright. All rights reserved.

Referência(s)